CC
ZY

Casdin Capital’s Zymergen Inc. Common Stock ZY Stock Holding History

Casdin Capital’s Portfolio ZY Stock Details ZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-30,000
Closed -$1.2M – 60
2021
Q2 		$1.2M Buy
+30,000
New +$1.18M 0.03% 53

Other funds holding ZY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return

Casdin Capital's ZY Position: Q3 2021 in Review

Casdin Capital sold out of Zymergen Inc. Common Stock (ZY) in Q3 2021, closing a stake of 30,000 shares — an estimated $1.2M sold.

Casdin Capital first reported a position in ZY in Q2 2021 and held it in 1 quarter. The position peaked at $1.2M in Q2 2021. 71 funds tracked by Wall St. Rank hold ZY as of Q3 2021.

  • Casdin Capital reported no remaining Zymergen Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Casdin Capital sold 30,000 Zymergen Inc. Common Stock shares in Q3 2021, an estimated $1.2M.
  • Casdin Capital first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Casdin Capital's Zymergen Inc. Common Stock position peaked at $1.2M in Q2 2021.
  • 71 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q3 2021.

Based on Casdin Capital's 13F filing for Q3 2021, filed 15 Nov 2021.